Emcure Pharmaceuticals (EMCURE) Share Price Falls 3.04% as Large Cap Stock Traded at Rs 1,767.60
- September 30, 2026
- Posted by: Kunal Singla
- Category: News
Emcure Pharmaceuticals Share Price is trading lower today after a 3.04% decline to Rs 1,767.60, leaving the company with a market capitalisation of Rs 34,586.15 crore. The move is relevant because Emcure Pharmaceuticals Share Price was at Rs 1,823.10 in the previous session and the stock is now tracking a fresh intraday price fall. The price move is confirmed in Univest data; a company-specific reason has not been established. For readers following Emcure Pharmaceuticals Share Price Today, the move places the stock among the day’s notable healthcare decliners while keeping the focus on price action, valuation and sector context rather than any unsupported trigger. Univest coverage for Emcure Pharmaceuticals Share Price also helps frame the latest trading update alongside the company’s fundamentals and peer positioning.
Emcure Pharmaceuticals Share Price matters today because the stock is moving while the broader market is still open, so the latest print gives a live reading of investor revaluation rather than a settled end-of-day outcome. Emcure Pharmaceuticals Stock News around this move is therefore about measurable price action, not speculation. Emcure Pharmaceuticals Share Price Today is also important because the company sits in the Large Cap category, which places today’s decline in a different context from a smaller company with the same percentage fall. Univest data shows the move clearly and allows a factual read-through of the share price fall, the fundamentals and the healthcare backdrop.
Emcure Pharmaceuticals (EMCURE) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,767.6 |
| Previous Close | Rs 1,823.1 |
| Today's Move | -Rs 55.50 (-3.04%) |
| Open | Rs 1,793.35 |
| High | Rs 1,825.1 |
| Low | Rs 1,767.6 |
| Market Capitalisation | Rs 34,586.15 crore |
| Market Cap Category | Large Cap |
Emcure Pharmaceuticals Share Price Today shows a clear intraday decline from Rs 1,823.10 to Rs 1,767.60, a drop of Rs 55.50 or 3.04%. The stock opened at Rs 1,793.35, touched a high of Rs 1,825.10 and touched a low of Rs 1,767.60, which is also the current price. That places Emcure Pharmaceuticals Share Price at the bottom of the day’s range at the time of writing. The company’s market capitalisation stands at Rs 34,586.15 crore, and the stock is classified as a Large Cap. For investors tracking Emcure Pharmaceuticals Share Price Live, the important point is that the decline is visible in real time and is not being presented here as a finished session outcome. Emcure Pharmaceuticals Share News will remain centred on the next price print and whether the stock holds above today’s low. Emcure Pharmaceuticals Share Price now moves into the fundamental lens for context.
Emcure Pharmaceuticals (EMCURE) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 34,586.15 crore |
| P/E Ratio | 34.2x |
| P/B Ratio | 6.61x |
| ROE | 20.09% |
| ROCE | 25.25% |
| EPS | Rs 53.31 |
| Book Value Per Share | Rs 275.72 |
| Dividend Yield | 0.2% |
Emcure Pharmaceuticals (EMCURE) fundamental metrics show P/E 34.2x, P/B 6.61x, ROE 20.09%, ROCE 25.25%. These ratios show where the company stands today and are not a call to buy or sell.
Emcure Pharmaceuticals has a market capitalisation of Rs 34,586.15 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 34.2x, P/B at 6.61x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 20.09% and ROCE of 25.25%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 53.31, book value per share of Rs 275.72, dividend yield of 0.2%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 30.95x, median ROE of 10.96%, median ROCE of 13.01%. Together they describe the fundamental backdrop without implying a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 34.2x |
| Benchmark Median P/E | 30.95x |
| Benchmark Average P/E | 46.82x |
| Benchmark P/E Range | 3.1x to 629.67x |
| Company P/B Ratio | 6.61x |
| Benchmark Median P/B | 2.82x |
| Benchmark Average P/B | 4.18x |
| Company ROE | 20.09% |
| Benchmark Median ROE | 10.96% |
| Benchmark Average ROE | 9.51% |
| Company ROCE | 25.25% |
| Benchmark Median ROCE | 13.01% |
| Benchmark Average ROCE | 12.48% |
| Company Market Capitalisation | Rs 34,586.15 crore |
| Benchmark Median Market Cap | Rs 720.23 crore |
| Benchmark Average Market Cap | Rs 13,282.41 crore |
Emcure Pharmaceuticals (EMCURE) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Emcure Pharmaceuticals (EMCURE) has a P/E ratio of 34.2x, which is above the benchmark median of 30.95x, a difference of +10.5%. A P/E difference of this kind is a reference point rather than a recommendation.
Emcure Pharmaceuticals (EMCURE) has a ROE of 20.09%, which is above the benchmark median of 10.96%, a difference of +83.3%. Emcure Pharmaceuticals (EMCURE) has a ROCE of 25.25%, which is above the benchmark median of 13.01%, a difference of +94.08%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,22,282.95 | 34.91 | 4.88 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,44,762.03 | 83.68 | 13.86 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,73,447.74 | 79.53 | 19.32 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,12,149.36 | 24.85 | 4.16 | 19.69 | 21.39 |
| Laurus Labs | LAURUSLABS | 1,11,250.29 | 101.75 | 19.73 | 18.31 | 18.2 |
Emcure Pharmaceuticals (EMCURE) has a P/E ratio of 34.2x compared with the displayed peer median of 79.53x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 20.09% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 25.25% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Emcure Pharmaceuticals (EMCURE) has a market capitalisation of Rs 34,586.15 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Emcure Pharmaceuticals
- Emcure Pharmaceuticals Share Price is trading lower by 3.04%, with the stock at Rs 1,767.60 during the session.
- Emcure Pharmaceuticals Share Price Today shows the current price at the day’s low, after an open at Rs 1,793.35 and a high of Rs 1,825.10.
- Emcure Pharmaceuticals Share Price carries a Large Cap market capitalisation of Rs 34,586.15 crore, which makes the move meaningful in company-size context.
- Emcure Pharmaceuticals Fundamental Analysis shows P/E of 34.2, P/B of 6.61, ROE of 20.09% and ROCE of 25.25%.
- Emcure Pharmaceuticals Stock News remains focused on how the price fall compares with the healthcare peer set and the industry benchmark.
About Emcure Pharmaceuticals
Emcure Pharmaceuticals operates in the pharmaceuticals and drugs industry within the healthcare sector. The company’s business is reflected in the financial metrics used by Univest: revenue generation, earnings, returns on capital and valuation multiples that investors often review together. Emcure Pharmaceuticals Share Price is therefore tracked not only for daily movement but also for what it signals about a large-cap healthcare company with a premium valuation profile. The stock’s market capitalisation, EPS, book value and return ratios together provide a compact snapshot of the business’s scale and profitability. For readers of Emcure Pharmaceuticals Share Price Today, the company sits within a competitive listed pharma universe where peer comparison is an important part of company overview and market analysis.
Track Emcure Pharmaceuticals Share Price on Univest
Use Emcure Pharmaceuticals (EMCURE) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
Track Emcure Pharmaceuticals Share Price on Univest for live price updates, fundamental ratios, 52-week levels and market insights in one place. The platform also helps readers follow Emcure Pharmaceuticals Stock News, valuation context, sector positioning and peer comparison without forcing a recommendation. If you want a steady view of Emcure Pharmaceuticals Share Price Today, Univest keeps the latest company data easy to review alongside broader market updates.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Emcure Pharmaceuticals Share Price falling today?
Ans. Emcure Pharmaceuticals Share Price is down 3.04% today and is trading at Rs 1,767.60. The price move is confirmed in Univest data; a company-specific reason has not been established. The previous close was Rs 1,823.1.
What is the current Emcure Pharmaceuticals Share Price?
Ans. Emcure Pharmaceuticals Share Price is Rs 1,767.60 at the time of writing. The stock opened at Rs 1,793.35 and moved between Rs 1,767.60 and Rs 1,825.10 during the session. The previous close was Rs 1,823.1.
How much did Emcure Pharmaceuticals Share Price decline today?
Ans. Emcure Pharmaceuticals Share Price declined by Rs 55.50, which equals 3.04% versus the previous close of Rs 1,823.10. That makes it one of the notable healthcare declines tracked in today’s update.
What is Emcure Pharmaceuticals market capitalisation?
Ans. Emcure Pharmaceuticals has a market capitalisation of Rs 34,586.15 crore. Univest classifies the company as a Large Cap, which gives today’s share price fall company-size context for readers following the stock.
What do Emcure Pharmaceuticals valuation ratios show?
Ans. Emcure Pharmaceuticals Share Price trades at a P/E of 34.2 and a P/B of 6.61. Those ratios sit above the industry median values, so the stock carries a premium valuation in the pharmaceuticals and drugs group.
How strong are Emcure Pharmaceuticals profitability ratios?
Ans. Emcure Pharmaceuticals reports ROE of 20.09% and ROCE of 25.25%. Both are above the benchmark medians in the same industry, which gives Emcure Pharmaceuticals Share Price a strong profitability backdrop despite today’s decline.
What do EPS and book value mean for Emcure Pharmaceuticals Share Price?
Ans. EPS is Rs 53.31, showing earnings attributable to each share, while book value is Rs 275.72 per share, showing accounting net worth behind each share. These figures help frame Emcure Pharmaceuticals Share Price in fundamental terms.
How does Emcure Pharmaceuticals compare with healthcare peers?
Ans. Emcure Pharmaceuticals Share Price sits below Sun Pharmaceutical, Divi's Laboratories and Torrent Pharmaceuticals in market capitalisation, but it shows stronger ROE than several peers and a P/E close to Sun Pharmaceutical’s level.
Should investors track Emcure Pharmaceuticals Share Price on Univest?
Ans. Yes, investors can track Emcure Pharmaceuticals Share Price on Univest for live updates, valuation ratios, market capitalisation, sector comparison and peer context. That keeps the stock’s price action and fundamentals in one view.
